Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

Annals of Neurology

Volumn 63, Issue 6, 2008, Pages 709-719

  Mesulam, Marsel ^a,d   Wicklund, Alissa ^a   Johnson, Nancy ^a   Rogalski, Emily ^a,b   Léger, Gabriel C ^a,c   Rademaker, Alfred ^a   Weintraub, Sandra ^a   Bigio, Eileen H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Northwestern Mesulam Center for Cognitive Neurology and Alzheimer's Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; AUTOPSY; BRAIN ASYMMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENTORHINAL CORTEX; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; MALE; MEMORY DISORDER; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPEECH DISORDER; TAUOPATHY; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APHASIA, PRIMARY PROGRESSIVE; ATROPHY; BIOLOGICAL MARKERS; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; PHENOTYPE;

EID: 46749090490     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21388     Document Type: Article

References (55)

1. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 1996;165(suppl):3-12.
2. Guillozet AL, Weintraub S, Mash DC, Mesulam M-M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729-736.
3. Bobinski M, Wegiel J, Wisniewski HM, et al. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 1996;17:909-919.
4. Jack CR, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003;60:253-260.
5. McKhann G, Drachman DA, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-944.
6. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007;130:2636-2645.
7. Johnson JK, Head E, Kim R, et al. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 1999;56:1233-1239.
8. Hof PR, Vogt BA, Bouras C, Morrison JH. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 1997;37:3609-3625.
9. Sonty SP, Mesulam M-M, Thompson CK, et al. Primary progressive aphasia: PPA and the language network. Ann Neurol 2003;53:35-49.
10. Rossor MN, Revesz T, Lantos PL, Warrington EK. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 2000;123:267-276.
11. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006;59:156-165.
12. Kertesz A, Hudson L, Mackenzie IRA, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
13. Turner RS, Kenyon LC, Trojanowski JQ, et al. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol 1996;39:166-173.
14. Mesulam M-M, Weintraub S. Spectrum of primary progressive aphasia. In: Rossor MN, ed. Unusual Dementias. London: Baillière Tindall, 1992:583-609.
15. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335-346.
16. Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain 2005;128:1996-2005.
17. Munoz DG, Woulfe J, Kertesz A. Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia. Acta Neuropathol 2007;114:347-357.
18. Mesulam M-M. Primary progressive aphasia: a language-based dementia. N Engl J Med 2003;348:1535-1542.
19. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006;20:210-216.
20. Rogalski E, Mesulam M-M. An update on primary progressive aphasia. Curr Neurol Neurosci Rep 2007;7:388-392.
21. Hyman BT, Trojanowski JQ. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer's disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. J Neuropathol Exp Neurol 1997;56:1095-1097.
22. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 2001;58:1803-1809.
23. Weintraub S, Rubin NP, Mesulam MM. Primary progressive aphasia. Longitudinal course, neuropsychological profile, and language features. Arch Neurol 1990;47:1329-1335.
24. Chawluk JB, Mesulam MM, Hurtig H, et al. Slowly progressive aphasia without generalized dementia: studies with positron emission tomography. Ann Neurol 1986;19:68-74.
25. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
26. Greene JDW, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol 1996;53:1072-1079.
27. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007;114:31-38.
28. Mesulam M-M, Johnson N, Grujic Z, Weintraub S. Apolipoprotein E genotypes in primary progressive aphasia. Neurology 1997;49:51-55.
29. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116.
30. Hyman BT, Damasio AR, Van Hoesen GW, Barnes CL. Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science 1984;298:83-95.
31. Mesulam M-M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999;24:521-529.
32. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
33. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004;63:1168-1174.
34. Hof PR, Bouras C, Constantinidis J, Morrison JH. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990;49:168-194.
35. Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology 1990;40:14-19.
36. Giannakopoulos P, Hof PR, Bouras C. Alzheimer disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases. Acta Neuropathol 1994;88:440-447.
37. Engel PA, Fleming PD. Primary progressive aphasia, left anterior atrophy, and neurofibrillary hippocampal pathology: observations in an unusual case. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:213-218.
38. Green J, Morris JC, Sandson J, et al. Progressive aphasia - a precursor of global dementia. Neurology 1990;40:423-429.
39. Kempler D, Metter EJ, Riege WH, et al. Slowly progressive aphasia: three cases with language, memory, CT and PET data. J Neurol Neurosurg Psychiatry 1990;53:987-993.
40. Li F, Iseki E, Kato M, et al. An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: a clinico-pathological and immunohistochemical study. Neuropathology 2000;20:239-245.
41. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484-498.
42. Jellinger KA. Alzheimer's changes in non-demented and demented patients. Acta Neuropathol 1995;89:112-113.
43. Davis DG, Schmitt A, Wekstein DR, Merkesberry WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999;58:376-388.
44. Amador-Ortiz C, Lin W-L, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61:435-445.
45. Grossman M, Farmer J, Leight S, et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005;57:721-729.
46. Nelissen N, Vandenbulcke M, Fannes K, et al. Aβ amyloid deposition in the language system and how the brain responds. Brain 2007;130:2055-2069.
47. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
48. Wechsler D. Wechsler Memory Scale-Revised Manual. San Antonio, TX: The Psychological Corporation, 1987.
49. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
50. Benton A, Hamsher KdS. Multilingual Aphasia Examination. Iowa City, IA: University of Iowa, 1989.
51. Goodglass H, Kaplan E, Barresi B. Boston Diagnostic Aphasia Examination. 3rd ed. Austin, TX: Pro-Ed, 2001.
52. Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests: administration, norms and commentary. 3rd ed. New York: Oxford University Press, 2006.
53. Warrington E. Recognition Memory Test manual. Windsor, United Kingdom: NFER-Nelson, 1984.
54. Weintraub S, Peavy GM, O'Connor M, et al. Three words - three shapes: a clinical test of memory. J Clin Exp Neuropsychol 2000;22:267-278.
55. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.